Pharmacological characteristics of Ro 115–1240, a selective α 1A/1L ‐adrenoceptor partial agonist: a potential therapy for stress urinary incontinence
Authors:
Open Access
- 17 December 2003
- journal article
- Published by Wiley in BJU International
- Vol. 93 (1) , 162-170
Abstract
OBJECTIVE: To describe the preclinical pharmacology of Ro 115–1240, a peripherally acting selective α 1A/1L ‐adrenoceptor (AR) partial agonist, compared with the α 1A/1L ‐AR full agonist amidephrine, as AR agonists have some utility in the treatment of stress urinary incontinence (SUI) but are limited by undesirable cardiovascular and central nervous system side‐effects. RESULTS: In radioligand‐binding studies Ro 115–1240 had greater affinity for α 1A than for α 1B and α 1D subtypes. The potency and intrinsic activity of amidephrine and Ro 115–1240 relative to noradrenaline were determined in native and cell‐based assays using human recombinant α 1 ‐ARs; they acted as selective α 1A/1L ‐AR full and partial agonists, respectively. In anaesthetized micropigs and rabbits, amidephrine and Ro 115–1240 produced non‐selective, dose‐dependent increases in intraurethral and arterial blood pressures but the magnitude of the pressure increases evoked by Ro 115–1240 were about a third of those with amidephrine. In conscious micropigs both agents produced dose‐dependent increases in urethral tension. Again, the magnitude of the urethral response to Ro 115–1240 was about a third of that with amidephrine. More importantly, only amidephrine produced dose‐dependent increases in blood pressure and decreases in heart rate. Ro 115–1240 produced a maximum increase in urethral tension with no effect on blood pressure or heart rate. CONCLUSION: These results show that by combining selectivity for the α 1A/1L ‐AR subtype with a reduction in intrinsic agonist efficacy, Ro 115–1240 has reduced haemodynamic effects while retaining to some degree the contractile effects on urethral smooth muscle. These studies indicate that Ro 115–1240 may be useful as a novel treatment for SUI.Keywords
This publication has 33 references indexed in Scilit:
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- CONGENITAL OBSTRUCTION OF THE POSTERIOR URETHRA 1Journal of Urology, 2002
- COMPARISON OF ??1-ADRENOCEPTOR AGONISTS IN CANINE URETHRAL PRESSURE PROFILOMETRY AND ABDOMINAL LEAK POINT PRESSURE MODELSJournal of Urology, 2001
- Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II studyInternational Urogynecology Journal, 1998
- α‐adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibilityBritish Journal of Clinical Pharmacology, 1996
- alpha-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibilityBritish Journal of Clinical Pharmacology, 1996
- α1A‐adrenoceptor subtype mediates contraction of the rat urethraJournal of Autonomic Pharmacology, 1994
- Inositol Phospholipid Hydrolysis in Rat Cerebral Cortical Slices: I. Receptor CharacterisationJournal of Neurochemistry, 1984
- Aspects on the physiology and pharmacology of the bladder and urethraProgress in Neurobiology, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973